Adtalem Global Education (NYSE:CVSA) CEO Sells $330,742.62 in Stock

Adtalem Global Education Inc. (NYSE:CVSA) CEO Stephen Beard sold 2,529 shares of the stock in a transaction on Thursday, June 11th. The shares were sold at an average price of $130.78, for a total value of $330,742.62. Following the completion of the sale, the chief executive officer directly owned 424,033 shares of the company’s stock, valued at $55,455,035.74. The trade was a 0.59% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Stock Down 2.8%

NYSE CVSA traded down $3.66 on Friday, reaching $128.23. The company had a trading volume of 295,964 shares, compared to its average volume of 254,545. The stock has a market capitalization of $4.36 billion, a PE ratio of 19.97, a P/E/G ratio of 1.09 and a beta of 0.62. The business has a fifty day moving average price of $120.70. Adtalem Global Education Inc. has a 52-week low of $86.97 and a 52-week high of $156.26. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.36.

Adtalem Global Education (NYSE:CVSA) last released its quarterly earnings results on Thursday, May 7th. The company reported $1.98 EPS for the quarter, beating analysts’ consensus estimates of $1.73 by $0.25. The business had revenue of $487.03 million during the quarter. Adtalem Global Education had a return on equity of 20.19% and a net margin of 12.26%.The company’s quarterly revenue was up 4.5% compared to the same quarter last year. During the same period in the previous year, the company posted $1.92 earnings per share. Adtalem Global Education has set its FY 2026 guidance at 7.950-8.150 EPS. On average, research analysts expect that Adtalem Global Education Inc. will post 8.04 EPS for the current year.

Wall Street Analyst Weigh In

A number of research firms recently commented on CVSA. Barrington Research reissued an “outperform” rating and issued a $170.00 price target on shares of Adtalem Global Education in a research report on Monday. Truist Financial increased their price target on Adtalem Global Education from $130.00 to $140.00 and gave the company a “buy” rating in a research report on Monday, May 11th. Wall Street Zen lowered Adtalem Global Education from a “buy” rating to a “hold” rating in a research report on Saturday, May 9th. Zacks Research lowered Adtalem Global Education from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, March 25th. Finally, Weiss Ratings reiterated a “hold (c+)” rating on shares of Adtalem Global Education in a research note on Friday, May 22nd. Two research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $155.00.

Adtalem Global Education Company Profile

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.